Photon-Counting Detector CT for Musculoskeletal Imaging: A Clinical Perspective

Area of Science:

• Medical Imaging
• Radiology
• Biomedical Engineering

Background:

• Photon-counting detector (PCD) CT represents a significant advancement in X-ray detection technology.
• The U.S. FDA approved the first commercial PCD CT system in 2021, following extensive research.
• PCD CT technology offers unique advantages for musculoskeletal imaging applications.

Purpose of the Study:

• To review the technical features of PCD CT.
• To evaluate the impact of PCD CT on musculoskeletal imaging applications.
• To compare PCD CT with conventional energy-integrating detector (EID) CT using clinical examples.

Main Methods:

• Review of technical specifications of PCD CT systems.
• Comparison of image quality and diagnostic capabilities between PCD CT and EID CT.
• Analysis of clinical cases showcasing PCD CT benefits in musculoskeletal imaging.

Main Results:

• PCD CT provides ultrahigh spatial resolution for imaging large joints and skeletal anatomy due to smaller detector pixels and high geometric dose efficiency.
• Advanced multienergy spectral postprocessing enables quantification of gout deposits and virtual noncalcium imaging for bone edema visualization.
• PCD CT demonstrates improved metal artifact reduction for orthopedic implants and enhanced contrast-to-noise ratio (CNR) with reduced electronic noise.
• PCD CT images show superior cortical and trabecular detail, leading to clearer depiction of fractures, lytic lesions, and mineralized tumor matrix.

Conclusions:

• PCD CT offers substantial improvements over EID CT for musculoskeletal imaging.
• Key advantages include enhanced spatial resolution, advanced spectral analysis capabilities, and superior artifact reduction.
• PCD CT facilitates more accurate and detailed visualization of skeletal abnormalities.